Form 4: Richard Malamut, Chromocell Therapeutics Director, Acquires Restricted Stock Units
SEC Form 4
Director Richard Malamut reports acquisition of restricted stock units in Chromocell Therapeutics.
Summary
- Richard Malamut, a director of Chromocell Therapeutics Corp, reported the acquisition of 64,498 restricted stock units (RSUs) on June 14, 2024.
- The RSUs have an exercise price of $1.30 per share and vest quarterly over two years.
- Following the transaction, Malamut directly owns 81,165 shares of Chromocell Therapeutics common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock unit acquisition. The director's acquisition could be seen as a positive sign, but it's not overtly bullish.
Positives
- Director's acquisition of RSUs may signal confidence in the company's future performance.
Future Outlook
The vesting schedule of the RSUs over the next two years suggests a long-term commitment by the director.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding insider transactions, allowing investors to monitor the actions of company insiders.
Stakeholder Impact
- Shareholders may view the director's acquisition of RSUs as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of the transaction: Richard Malamut was granted restricted stock units to purchase 64,498 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years. |
| 06/18/2024 | Date of signature for the Form 4 filing. |
| 06/14/2034 | Expiration date of the restricted stock units. |
Keywords
Chromocell Therapeutics, Richard Malamut, restricted stock units, director, Form 4, beneficial ownership, equity securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.